Kelleher Financial Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-2,000
| Closed | -$23K | – | 115 |
|
2022
Q3 | $23K | Hold |
2,000
| – | – | 0.02% | 114 |
|
2022
Q2 | $22K | Hold |
2,000
| – | – | 0.01% | 134 |
|
2022
Q1 | $59K | Sell |
2,000
-8,000
| -80% | -$236K | 0.03% | 115 |
|
2021
Q4 | $265K | Hold |
10,000
| – | – | 0.14% | 105 |
|
2021
Q3 | $363K | Hold |
10,000
| – | – | 0.16% | 113 |
|
2021
Q2 | $434K | Hold |
10,000
| – | – | 0.24% | 71 |
|
2021
Q1 | $342K | Sell |
10,000
-1,300
| -12% | -$44.5K | 0.22% | 76 |
|
2020
Q4 | $395K | Hold |
11,300
| – | – | 0.3% | 69 |
|
2020
Q3 | $271K | Buy |
+11,300
| New | +$271K | 0.22% | 75 |
|